Get the Stockscreener App
4.64
1.49%
-0.07
After Hours:
4.60
-0.04
-0.86%
Nexentis Technologies Inc stock is traded at $4.64, with a volume of 7,244.
It is down -1.49% in the last 24 hours and up +10.21% over the past month.
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
See More
Previous Close:
$4.71
Open:
$5.11
24h Volume:
7,244
Relative Volume:
0.47
Market Cap:
$3.39M
Revenue:
$208.50K
Net Income/Loss:
$-6.85M
P/E Ratio:
-0.0667
EPS:
-69.6012
Net Cash Flow:
$-2.92M
1W Performance:
-20.68%
1M Performance:
+10.21%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$4.5387
$5.11
1-Week Range:
$4.5387
$5.48
52-Week Range:
$3.38
$7.56
Nexentis Technologies Inc Stock (NXTS) Company Profile
Name
Nexentis Technologies Inc
Sector
Industry
Phone
972544561349
Address
156 FIFTH AVENUE 10TH FLOOR, NEW YORK
Compare NXTS vs CTVA, NTR, CF, ICL, MOS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXTS
Nexentis Technologies Inc
|
4.64 | 3.44M | 208.50K | -6.85M | -2.92M | -69.60 |
CTVA
Corteva Inc
|
83.30 | 55.75B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
70.94 | 34.22B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
122.97 | 19.28B | 7.41B | 2.12B | 1.62B | 11.13 |
ICL
Icl Group Ltd
|
6.57 | 8.80B | 7.15B | 280.00M | 137.88M | 0.1749 |
MOS
Mosaic Company
|
22.68 | 7.24B | 12.05B | 575.40M | -534.60M | 1.6871 |
Nexentis Technologies Inc Stock (NXTS) Latest News
Nexentis Technologies (NASDAQ: NXTS) posts Q1 2026 loss, flags going concern risk - Stock Titan
Nexentis subsidiary achieves drug discovery milestone By Investing.com - Investing.com Australia
Nexentis Technologies Inc. Announces Drug Discovery Milestone Achieved by MitoCareX Utilizing MITOLINE® Platform - Quiver Quantitative
Nexentis algorithm shapes new drug candidate for tough cancers, inflammation - Stock Titan
Nexentis Technologies Inc. (NXTS) - Zacks Investment Research
Number of shareholders of Nexentis Technologies Inc. – NASDAQ:NXTS - TradingView
Nexentis Technologies Secures US Trademark Approval for MitoCareX Algorithm Platform MITOLINE - ChemAnalyst
Nexentis Technologies stock jumps on trademark approval - Investing.com
Nexentis subsidiary receives U.S. trademark for drug platform By Investing.com - Investing.com South Africa
Nexentis Technologies stock jumps on trademark approval By Investing.com - Investing.com Canada
Nexentis subsidiary receives U.S. trademark for drug platform - Investing.com
Drug discovery firm secures U.S. trademark for its MITOLINE platform - Stock Titan
Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX’s Algorithm Platform MITOLINE™ - Yahoo Finance
NXTS (Nexentis Technologies) falls 2.62% after Q2 2025 earnings with no consensus performance benchmarks available.FCF Yield - newser.com
Nexentis Shareholders Approve Reverse Split and Financing Flexibility - The Globe and Mail
Shareholders back Nexentis (NITO) reverse split and equity financing plans - Stock Titan
[EFFECT] Nexentis Technologies Inc. SEC Filing - Stock Titan
NXTS Price History for Nexentis Technologies Stock - Barchart.com
Nexentis Technologies (NXTS) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
NXTS News | NEXENTIS TECHNOLOGIES INC (NASDAQ:NXTS) - ChartMill
Nexentis Technologies Inc. (NXTS) Cash Equivalents (Quarterly) - Zacks Investment Research
Nexentis Technologies (NXTS) Stock: Breaking Downtrend? (Soars) 2026-04-20Beta Signals - Cổng thông tin điện tử tỉnh Lào Cai
Top Nexentis Technologies (NXTS) Competitors 2026 - MarketBeat
Nexentis Technologies (NXTS) Earnings Date and Reports 2026 - MarketBeat
Nexentis Technologies Incmay offer up to $100 million of securitiesSEC filing - marketscreener.com
[S-3] Nexentis Technologies Inc. Shelf Registration Statement - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Nexentis Technologies (NXTS) Institutional Ownership 2026 - MarketBeat
Nexentis Technologies (NXTS) Stock Price, News & Analysis - MarketBeat
Debt to assets ratio of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Total liabilities of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Revenue per share of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Nexentis Technologies Inc. Statistics – LS:A425ME - TradingView
Non-controlling/minority interest of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Enterprise value to EBITDA ratio of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Total debt per share of Nexentis Technologies Inc. – LS:A425ME - TradingView
Net debt of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Tangible book value per share of Nexentis Technologies Inc. – LS:A425ME - TradingView
Preferred dividends of Nexentis Technologies Inc. – LS:A425ME - TradingView
EBIT of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Nexentis Technologies Inc. Balance Sheet – LS:A425ME - TradingView — Track All Markets
Gross profit of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Nexentis Technologies Inc. Cash Flow – LS:A425ME - TradingView — Track All Markets
Dilution adjustment of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
EBITDA of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Operating income of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Average basic shares outstanding of Nexentis Technologies Inc. – LS:A425ME - TradingView
Nexentis Technologies Inc. Income Statement – LS:A425ME - TradingView
Net income of Nexentis Technologies Inc. – LS:A425ME - TradingView — Track All Markets
Nexentis Technologies Inc. Earnings and Revenue – LS:A425ME - TradingView — Track All Markets
Nexentis Technologies Inc Stock (NXTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.08%
6.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):